Mint Tower Capital Management
AEON icon

Mint Tower Capital Management’s AEON Biopharma AEON Stock Holding History

Mint Tower Capital Management’s Portfolio AEON Stock Details AEON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-3,254
Closed -$2.36M – 291
2022
Q4 		$2.36M Buy
3,254
+1,907
+142% +$1.37M 0.21% 78
2022
Q3 		$955K Buy
+1,347
New +$954K 0.07% 267

Other funds holding AEON

Saba Capital Management
Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return
Glazer Capital LLC
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
Fir Tree Capital Management
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
Empyrean Capital Partners
Empyrean Capital Partners Los Angeles, California $3.03B AUM 47.81% 1-Year Est. Return
Tenor Capital Management
Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return
Periscope Capital
Periscope Capital Toronto, Ontario, Canada $990M AUM 4.73% 1-Year Est. Return
Sandia Investment Management
Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return
CCA
Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return
Shaolin Capital Management
Shaolin Capital Management Miami, Florida $2.1B AUM 64.05% 1-Year Est. Return
Meteora Capital
Meteora Capital Boca Raton, Florida $1.21B AUM 13.69% 1-Year Est. Return

Mint Tower Capital Management's AEON Position: Q1 2023 in Review

Mint Tower Capital Management sold out of AEON Biopharma (AEON) in Q1 2023, closing a stake of 3,254 shares — an estimated $2.36M sold.

Mint Tower Capital Management first reported a position in AEON in Q3 2022 and held it in 2 quarters. The position peaked at $2.36M in Q4 2022. 21 funds tracked by Wall St. Rank hold AEON as of Q1 2023.

  • Mint Tower Capital Management reported no remaining AEON Biopharma position as of Q1 2023 after selling out during the quarter.
  • Mint Tower Capital Management sold 3,254 AEON Biopharma shares in Q1 2023, an estimated $2.36M.
  • Mint Tower Capital Management first reported a position in AEON Biopharma in Q3 2022 and held it in 2 quarters.
  • Mint Tower Capital Management's AEON Biopharma position peaked at $2.36M in Q4 2022.
  • 21 funds tracked by Wall St. Rank held AEON Biopharma as of Q1 2023.

Based on Mint Tower Capital Management's 13F filing for Q1 2023, filed 9 May 2023.